Stefanie Brehmer

DNA methylation-based classification of central nervous system tumours

David Capper, David Jones, Martin Sill et al. · Nature · 2018 · 2.9K citations · Full text

Neuro-oncology, Dna Methylation-based Classification, Medicine +7

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis

Felix Sahm, Daniel Schrimpf, Damian Stichel et al. · The Lancet Oncology · 2017 · 814 citations · Full text

Chromatin, Mendelian Disorder, Dna Methylation-based Classification +12

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

Ulrich Herrlinger, Theophilos Tzaridis, Frederic Mack et al. · The Lancet · 2019 · 556 citations · Full text

Hematological Malignancy, Neuro-oncology, Treatment Strategies +13

TERT Promoter Mutations and Risk of Recurrence in Meningioma

Felix Sahm, Daniel Schrimpf, Adriana Olar et al. · JNCI Journal of the National Cancer Institute · 2015 · 393 citations · Full text

Prognostic Biomarkers, World Health Organization, Somatic Variant +14

Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O⁶-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial

Ulrich Herrlinger, Niklas Schäfer, Astrid Weyerbrock et al. · Journal of Clinical Oncology · 2016 · 194 citations